Collaborations (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Change in Accounts Receivable, Contract Asset and Liabilities

The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2025 (in thousands):

	Balance at December 31, 2024		Additions		Deductions			Balance at December 31, 2025
Accounts receivable and contract assets:
Billed receivables – Sanofi	$	—	$	20,947	$	(20,947	)	$	—
Unbilled receivables – Sanofi		947		20,000		(20,947	)		—
Billed receivables – Gilead		—		40,000		(40,000	)		—
Total accounts receivable and contract assets	$	947	$	80,947	$	(81,894	)	$	—
Contract Liabilities:
Deferred Revenue – Sanofi		13,576		20,000		(33,576	)		—
Deferred Revenue - Gilead		—		40,000		(5,635	)		34,365
Total contract liabilities	$	13,576	$	60,000	$	(39,211	)	$	34,365